 Immunosuppression
"Immunosuppression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.
| Descriptor ID |
D007165
|
| MeSH Number(s) |
E02.095.465.425.450 E05.478.610
|
| Concept/Terms |
Immunosuppression- Immunosuppression
- Immunosuppressions
- Therapy, Anti-Rejection
- Anti-Rejection Therapy
- Anti Rejection Therapy
- Anti-Rejection Therapies
- Therapy, Antirejection
- Antirejection Therapies
- Antirejection Therapy
|
Below are MeSH descriptors whose meaning is more general than "Immunosuppression".
Below are MeSH descriptors whose meaning is more specific than "Immunosuppression".
This graph shows the total number of publications written about "Immunosuppression" by people in Harvard Catalyst Profiles by year, and whether "Immunosuppression" was a major or minor topic of these publication.
Below are the most recent publications written about "Immunosuppression" by people in Profiles.
-
Wing-See Lau T, Wong IY, Sobrin L. Diagnostic and therapeutic challenges. Retina. 2012 Sep; 32(8):1674-7.
-
Zhu X, McTiernan CF, Rajagopalan N, Shah H, Fischer D, Toyoda Y, Letts D, Bortinger J, Gibson G, Xiang W, McCurry K, Mathier M, Glorioso JC, London B. Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression. Hum Gene Ther. 2012 Jul; 23(7):722-32.
-
Riella LV, Chandraker A. Stem cell therapy in kidney transplantation. JAMA. 2012 Jul 11; 308(2):130; author reply 130-1.
-
Silberman D, Bucknum A, Bartlett T, Composto G, Kozlowski M, Walker A, Werda A, Cua J, Sharpe AH, Somerville JE, Riggs JE. CD28 ligation increases macrophage suppression of T-cell proliferation. Cell Mol Immunol. 2012 Jul; 9(4):341-9.
-
Green MR, Rodig S, Juszczynski P, Ouyang J, Sinha P, O'Donnell E, Neuberg D, Shipp MA. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res. 2012 Mar 15; 18(6):1611-8.
-
Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, Tchao NK. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA. 2012 Jan 18; 307(3):283-93.
-
Patil SU, Shreffler WG. Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation. Clin Exp Immunol. 2012 Jan; 167(1):59-66.
-
Leonard DA, Gordon CR, Sachs DH, Cetrulo CL. Immunobiology of face transplantation. J Craniofac Surg. 2012 Jan; 23(1):268-71.
-
Scalea J, Hanecamp I, Robson SC, Yamada K. T-cell-mediated immunological barriers to xenotransplantation. Xenotransplantation. 2012 Jan-Feb; 19(1):23-30.
-
Sugiyama K, Isogai K, Horisawa S, Toyama A, Satoh H, Saito K, Nakagawa Y, Tasaki M, Takahashi K, Hirano T. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab. Cell Transplant. 2012; 21(2-3):565-70.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|